Sonoma Pharmaceuticals, Inc.
SNOA· Nasdaq
SNOASonoma Pharmaceuticals, Inc.
Filed Nov 19, 2013 · 10-Q · 50 days after period end · 0001019687-13-004492
| Metric | Q2 2014 | Q2 2010 |
|---|---|---|
| Revenue | $4.09M | $2.47M |
| Net Income | -$1.40M | -$1.65M |
| EPS Diluted | -$0.21 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sonoma Pharmaceuticals, Inc. · CIK 1367083 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 19, 2013 · 50 d after period end
